• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Chemother . Antiviral Treatment for Influenza in Japan

tetano

Editor, Senior Moderator
J Infect Chemother


. 2025 Jun 18:102760.
doi: 10.1016/j.jiac.2025.102760. Online ahead of print. Antiviral Treatment for Influenza in Japan

Tadashi Ishida[SUP] 1 [/SUP]



Affiliations
Abstract

Anti-influenza drugs reduce the viral load, which leads to improvement of symptoms, a reduced illness period, suppression of complications, and protection from transmission. It is desirable to administer antiviral drugs within 48 hours of the onset of symptoms. The use of antiviral drugs is limited mainly to individuals who are hospitalized, those who have severe, complicated, or progressive illness, or those who are at high risk for influenza complications in western countries. On the other hand, in Japan, anti-influenza drugs have been widely used from the onset of the disease by general practitioners in order to ease symptoms, that leads to suppressed development of severe complications. Five drugs for influenza are available in Japan at present, which is thought to be that influenza treatment in Japan is the advanced one in the world. Baloxavir, the newest anti-influenza drug which has different mechanism from neuraminidase inhibitors rapidly reduce viral loads. Baloxavir is recommended as oseltamivir for the treatment of influenza.

Keywords: Anti-influenza drugs; Antiviral resistant virus; Baloxavir marboxil; Neuraminidase inhibitor.

 
Back
Top